1
|
Lasham A, Print CG, Woolley AG, Dunn SE
and Braithwaite AW: YB-1: Oncoprotein, prognostic marker and
therapeutic target? Biochem J. 449:11–23. 2013. View Article : Google Scholar
|
2
|
Ohga T, Koike K, Ono M, Makino Y, Itagaki
Y, Tanimoto M, Kuwano M and Kohno K: Role of the human Y
box-binding protein YB-1 in cellular sensitivity to the
DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
Cancer Res. 56:4224–4228. 1996.PubMed/NCBI
|
3
|
Kuwano M, Uchiumi T, Hayakawa H, Ono M,
Wada M, Izumi H and Kohno K: The basic and clinical implications of
ABC transporters, Y-box-binding protein-1 (YB-1) and
angiogenesis-related factors in human malignancies. Cancer Sci.
94:9–14. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Shibahara K, Sugio K, Osaki T, Uchiumi T,
Maehara Y, Kohno K, Yasumoto K, Sugimachi K and Kuwano M: Nuclear
expression of the Y-box binding protein, YB-1, as a novel marker of
disease progression in non-small cell lung cancer. Clin Cancer Res.
7:3151–3155. 2001.PubMed/NCBI
|
5
|
Antisense Drug Technology. Principles,
Strategies, and Applications. 2nd edition. Crooke ST: CRC Press;
Boca Raton, FL: 2007
|
6
|
Gene Silencing by RNA Interference:
Technology and Application. 1st edition. Sohail M: CRC Press; Boca
Raton, FL: 2004, View Article : Google Scholar
|
7
|
Mintzer MA and Simanek EE: Nonviral
vectors for gene delivery. Chem Rev. 109:259–302. 2009. View Article : Google Scholar
|
8
|
Harada T, Misaki A and Saito H: Curdlan: A
bacterial gelforming beta-1,3-glucan. Arch Biochem Biophys.
124:292–298. 1968. View Article : Google Scholar : PubMed/NCBI
|
9
|
Sakurai K and Shinkai S: Molecular
recognition of adenine, cytosine, and uracil in a single-stranded
RNA by a natural polysaccharide: Schizophyllan. J Am Chem Soc.
122:4520–4521. 2000. View Article : Google Scholar
|
10
|
Sakurai K, Mizu M and Shinkai S:
Polysaccharide-polynucleotide complexes. 2 Complementary
polynucleotide mimic behavior of the natural polysaccharide
schizophyllan in the macromolecular complex with single-stranded
RNA and DNA. Biomacromolecules. 2:641–650. 2001. View Article : Google Scholar : PubMed/NCBI
|
11
|
Sanada Y, Matsuzaki T, Mochizuki S,
Okobira T, Uezu K and Sakurai K: β-1,3-D-glucan
schizophyllan/poly(dA) triple-helical complex in dilute solution. J
Phys Chem B. 116:87–94. 2012. View Article : Google Scholar
|
12
|
Kobiyama K, Aoshi T, Narita H, Kuroda E,
Hayashi M, Tetsutani K, Koyama S, Mochizuki S, Sakurai K, Katakai
Y, et al: Nonagonistic Dectin-1 ligand transforms CpG into a
multitask nanoparticulate TLR9 agonist. Proc Natl Acad Sci USA.
111:3086–3091. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Mochizuki S, Morishita H and Sakurai K:
Macrophage specific delivery of TNF-α siRNA complexed with
β-1,3-glucan inhibits LPS-induced cytokine production in a murine
acute hepatitis model. Bioorg Med Chem. 21:2535–2542. 2013.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhang Q, Ichimaru N, Higuchi S, Cai S, Hou
J, Fujino M, Nonomura N, Kobayashi M, Ando H, Uno A, et al:
Permanent acceptance of mouse cardiac allografts with CD40 siRNA to
induce regulatory myeloid cells by use of a novel polysaccharide
siRNA delivery system. Gene Ther. 22:217–226. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Heyl KA, Klassert TE, Heinrich A, Müller
MM, Klaile E, Dienemann H, Grünewald C, Bals R, Singer BB and
Slevogt H: Dectin-1 is expressed in human lung and mediates the
proin-flammatory immune response to nontypeable Haemophilus
influenzae. MBio. 5:e01492–e14. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Mylona E, Melissaris S, Giannopoulou I,
Theohari I, Papadimitriou C, Keramopoulos A and Nakopoulou L:
Y-box-binding protein 1 (YB1) in breast carcinomas: Relation to
aggressive tumor phenotype and identification of patients at high
risk for relapse. Eur J Surg Oncol. 40:289–296. 2014. View Article : Google Scholar
|
17
|
Tanabe M, Izumi H, Ise T, Higuchi S,
Yamori T, Yasumoto K and Kohno K: Activating transcription factor 4
increases the cisplatin resistance of human cancer cell lines.
Cancer Res. 63:8592–8595. 2003.PubMed/NCBI
|
18
|
Izumi H, Takahashi M, Uramoto H, Nakayama
Y, Oyama T, Wang KY, Sasaguri Y, Nishizawa S and Kohno K:
Monocarboxylate transporters 1 and 4 are involved in the invasion
activity of human lung cancer cells. Cancer Sci. 102:1007–1013.
2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kashiwagi E, Izumi H, Yasuniwa Y, Baba R,
Doi Y, Kidani A, Arao T, Nishio K, Naito S and Kohno K: Enhanced
expression of nuclear factor I/B in oxaliplatin-resistant human
cancer cell lines. Cancer Sci. 102:382–386. 2011. View Article : Google Scholar
|
20
|
Takahashi M, Shimajiri S, Izumi H, Hirano
G, Kashiwagi E, Yasuniwa Y, Wu Y, Han B, Akiyama M, Nishizawa S, et
al: Y-box binding protein-1 is a novel molecular target for tumor
vessels. Cancer Sci. 101:1367–1373. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zuker M: Mfold web server for nucleic acid
folding and hybridization prediction. Nucleic Acids Res.
31:3406–3415. 2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Mochizuki S, Morishita H, Adachi Y,
Yamaguchi Y and Sakurai K: Binding assay between murine Dectin-1
and β-glucan/DNA complex with quartz-crystal microbalance.
Carbohydr Res. 391:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|